Drugs / Indium-111 Pentreotide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02546388 | Oct 2015 → Aug 2018 | cardiac sarcoidosis | Marcelo F. Di Carli, MD, FACC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indium-111 Pentreotide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02546388 ↗ |
| Modality | Diagnostic / imaging agent | “FDA-approved radiotracer” NCT02546388 ↗ |